Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs
Traditional Chinese Drugs has proven to have unique merits in treating chronic atrophic gastritis (CAG) , but needs to be verified further by high-quality large-sample clinical studies. We detailed the technique essentials of clinical trial protocol design and assessment for CAG treated with Traditi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese General Practice Publishing House Co., Ltd
2022-07-01
|
| Series: | Zhongguo quanke yixue |
| Subjects: | |
| Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/zx2022010413.pdf |
| _version_ | 1797217172289748992 |
|---|---|
| author | Tianyuan WANG, Bo LI, Guozhen ZHAO, Jing HU, Hong WANG, Shuo FENG, Huina ZHANG |
| author_facet | Tianyuan WANG, Bo LI, Guozhen ZHAO, Jing HU, Hong WANG, Shuo FENG, Huina ZHANG |
| author_sort | Tianyuan WANG, Bo LI, Guozhen ZHAO, Jing HU, Hong WANG, Shuo FENG, Huina ZHANG |
| collection | DOAJ |
| description | Traditional Chinese Drugs has proven to have unique merits in treating chronic atrophic gastritis (CAG) , but needs to be verified further by high-quality large-sample clinical studies. We detailed the technique essentials of clinical trial protocol design and assessment for CAG treated with Traditional Chinese Drugs, which may be used as a methodological reference for clinical trial protocol design for CAG treated using Traditional Chinese Drugs, promoting the quality improvement of relevant studies. Then we discussed the essentials of relevant clinical trial protocol design, especially the selection of outcome indicators, in accordance with the attributes of Traditional Chinese Drugs, and features and actual needs of such trials, providing ideas for comprehensive evaluation of efficacy of Traditional Chinese Drugs in treating CAG. |
| first_indexed | 2024-04-24T11:57:38Z |
| format | Article |
| id | doaj.art-75c04baa48254fdca4e04b77ac19d339 |
| institution | Directory Open Access Journal |
| issn | 1007-9572 |
| language | zho |
| last_indexed | 2024-04-24T11:57:38Z |
| publishDate | 2022-07-01 |
| publisher | Chinese General Practice Publishing House Co., Ltd |
| record_format | Article |
| series | Zhongguo quanke yixue |
| spelling | doaj.art-75c04baa48254fdca4e04b77ac19d3392024-04-09T03:37:47ZzhoChinese General Practice Publishing House Co., LtdZhongguo quanke yixue1007-95722022-07-0125202519252410.12114/j.issn.1007-9572.2022.0065Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese DrugsTianyuan WANG, Bo LI, Guozhen ZHAO, Jing HU, Hong WANG, Shuo FENG, Huina ZHANG01Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China;2Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China;3Beijing Evidence-based Chinese Medicine Center, Beijing 100010, China;4Beijing University of Chinese Medicine, Beijing 100029, ChinaTraditional Chinese Drugs has proven to have unique merits in treating chronic atrophic gastritis (CAG) , but needs to be verified further by high-quality large-sample clinical studies. We detailed the technique essentials of clinical trial protocol design and assessment for CAG treated with Traditional Chinese Drugs, which may be used as a methodological reference for clinical trial protocol design for CAG treated using Traditional Chinese Drugs, promoting the quality improvement of relevant studies. Then we discussed the essentials of relevant clinical trial protocol design, especially the selection of outcome indicators, in accordance with the attributes of Traditional Chinese Drugs, and features and actual needs of such trials, providing ideas for comprehensive evaluation of efficacy of Traditional Chinese Drugs in treating CAG.https://www.chinagp.net/fileup/1007-9572/PDF/zx2022010413.pdfgastritis, atrophic|traditional chinese drugs|clinical trial|research design|root cause analysis |
| spellingShingle | Tianyuan WANG, Bo LI, Guozhen ZHAO, Jing HU, Hong WANG, Shuo FENG, Huina ZHANG Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs Zhongguo quanke yixue gastritis, atrophic|traditional chinese drugs|clinical trial|research design|root cause analysis |
| title | Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs |
| title_full | Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs |
| title_fullStr | Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs |
| title_full_unstemmed | Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs |
| title_short | Thoughts on Key Factors of Clinical Trial Protocol Design for Chronic Atrophic Gastritis Treated with Traditional Chinese Drugs |
| title_sort | thoughts on key factors of clinical trial protocol design for chronic atrophic gastritis treated with traditional chinese drugs |
| topic | gastritis, atrophic|traditional chinese drugs|clinical trial|research design|root cause analysis |
| url | https://www.chinagp.net/fileup/1007-9572/PDF/zx2022010413.pdf |
| work_keys_str_mv | AT tianyuanwangboliguozhenzhaojinghuhongwangshuofenghuinazhang thoughtsonkeyfactorsofclinicaltrialprotocoldesignforchronicatrophicgastritistreatedwithtraditionalchinesedrugs |